Drs. Hobbs and Mounsey respond.

摘要

I was glad to see reduced libido in women addressed in Clinical Inquiries (Which treatments help women with reduced libido? J Fam Pract. 2013;62:102, 112), but after reading it, I was disappointed. The main recommendation was for the use of a transdermal testosterone patch. The authors correctly note that the FDA doesn't recommend androgens for female sexual dysfunction, but fail to clarify that no androgen has been approved, let alone recommended, for this purpose. The article concludes by stating that "The North American Menopause Society recommends testosterone therapy for postmenopausal women with HSDD" [hypoactive sexual desire disorder]-a statement supported by a reference to a 2007 commentary on the topic. Looking at the original source reveals that this recommendation is from 2005 and has been officially "retired" by NAMS.